Vave Health Enhances Wireless Handheld Universal Product with Expanded Imaging Presets for Comprehensive and Cost-Effective Care

Musculoskeletal, Soft Tissue, and Bladder presets as well as enhanced measurement calculations highlight continuous innovation of Vave’s whole-body single probe

SAN JOSE, Calif., July 8, 2025 /PRNewswire/ — Vave Health, a leader in wireless, whole-body handheld ultrasound solutions, proudly announces a new wave of feature enhancements designed to further empower healthcare professionals. With these updates, Vave Health continues its mission to bring affordable, ultra-portable imaging technology that is straightforward and accessible for all.

Launched in March 2025, the Universal Probe is designed for continuous improvement, with quarterly updates delivered at no additional cost to health care professionals utilizing the device.

“Vave prides itself on lifetime value of the product, so what you pay up-front is what it costs for the probe. There is no subscription model, and all new updates are pushed via software at no cost to the end user,” states Amin Nikoozadeh, Founder and CEO of Vave Health.

Universal Probe: Enhanced Diagnostic Tools
The Universal Probe now boasts several cutting-edge updates to enhance its diagnostic capabilities:

  • New Linear Presets: Introduction of MSK (Musculoskeletal) and Soft Tissue presets expand the probe’s linear imaging capabilities.
     
  • Bladder Volume Calculations: A guided, two-plane measurement system that provides bladder volume, enhancing accuracy and efficiency.
     
  • Color Mode Enhancements: Improved Color Mode for the Abdominal preset, providing clearer, more detailed images for patient assessment.
     
  • Deep Imaging Support: Now available for both the Abdominal and Cardiac presets, enabling improved imaging for diverse body types.
     
  • Additional improvements include enhanced heat management, improved sync behavior, and overall software and QA performance.

“At Vave, our mission is to equip all healthcare providers with the tools they need for the best patient care. We are proud that each release is driven by customer feedback and requests and we embrace a continuous improvement mindset,” says Renee Dversdal, Chief Medical Officer of Vave Health.

About Vave Health
Founded by a Stanford University Ph.D. specializing in imaging system miniaturization, Vave Health is dedicated to delivering high-quality diagnostic tools at the point of care. Our state-of-the-art, ultraportable solution is headquartered in San Jose, California, and is setting new standards in medical imaging technology and solutions.

For more information, please visit vavehealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vave-health-enhances-wireless-handheld-universal-product-with-expanded-imaging-presets-for-comprehensive-and-cost-effective-care-302499419.html

SOURCE Vave Health

Staff

Recent Posts

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

3 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

3 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

3 hours ago

RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents

AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment…

3 hours ago

NYSE Content Advisory: Pre-Market Update + Cast of HBO’s ‘Industry’ Rang Thursday’s Closing Bell

NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

3 hours ago

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national…

3 hours ago